ISTH 2020 Congress
Venous Thromboembolism and Cardioembolism » VTE Treatment
Theme Navigation
Abstract Number: PB2423
90-Day Follow up in Patients with Suspected Deep Vein Thromboses (DVT) who Have Had a DVT Excluded: Should this Be Routine Clinical Practice?
Abstract Number: PB2454
A Case Report of Deep Vein Thrombosis after Kidney Transplantation
Abstract Number: PB2481
A Single Centre Experience on the Use of Direct Oral Anticoagulants in People with Human Immunodeficiency Virus (HIV)
Abstract Number: PB2469
An Evaluation of the Basis for Anti-Xa Testing in Patients on Low Molecular Weight Heparin and its Impact on Subsequent Management
Abstract Number: PB2443
Analysis of Outcomes Following Inferior Vena Cava (IVC) Filter Placement in a Single Center Population
Abstract Number: PB2442
Anticoagulant Therapy for Splanchnic Vein Thrombosis in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
Abstract Number: PB2460
Anticoagulation Control with the Point-of-Care INR: A Retrospective Pre-/Post-analysis
Abstract Number: PB2445
Anticoagulation in Cirrhosis: Thrombin Generation Assay vs Anti FXa Activity
Abstract Number: PB2450
Antithrombin III Levels Immediately Following Acute Venous Thromboembolism
Abstract Number: PB2452
Antithrombotic Stewardship: A Novel Approach to Appropriate Anticoagulant Prescription
Abstract Number: PB2399
Apixaban versus Heparin/Warfarin Treatment in Pulmonary Embolism: Results from the UK Apixaban Length-of-Stay Pulmonary Embolism – Hospital Admissions Study (ALPHA-PE)
Abstract Number: PB2485
Appropriateness of Direct Oral Anticoagulant Prescriptions in Emergency Department Outpatients with Acute Deep Vein Thrombosis
Abstract Number: PB2461
Association Between Index VTE Event and 12-Months Outcomes for Patients in Routine Clinical Practice Enrolled in the ETNA-VTE-Europe Registry
Abstract Number: PB2491
Biological and Pharmacological Profiling of Pentosan Polysulfate (PPS) in Comparison to Heparin and its Relative Neutralization by Protamine Sulfate
Abstract Number: PB2468
Cerebral Vein Thrombosis Treatment with Direct Oral Anticoagulants: A Case Series
Abstract Number: PB2448
Clinical Characteristics and Outcomes of Non-cancer, Non-CVC Associated upper Extremity DVT
Abstract Number: PB2451
Concentration Levels of Direct Oral Anticoagulants and Clinical Relevance in a Tertiary Hospital
Abstract Number: PB2475
Correlation between Anti-Xa Activity and Plasmatic Levels of Apixaban
Abstract Number: PB2473
Correlation of Reperfusion Therapy and In-hospital Mortality in Patients with Intermediate Risk Acute Pulmonary Embolism and Right Ventricular Dysfunction
Abstract Number: PB2402
Demographics and Clinical Outcomes of Older Adults Treated for Acute Venous Thromboembolism